HB2049 Summary

• Adds autism spectrum disorder with specific symptoms (agitation, rage attacks, self-injurious behavior) as a debilitating medical condition qualifying patients for medical marijuana use.

• Requires physicians treating patients under 18 years old with autism to provide written recommendations on marijuana potency, quantity, and frequency of use to the designated caregiver.

• Mandates monthly physician assessments of pediatric autism patients until a stable beneficial dose is established, then monitoring every six months.

• Requires physicians to report annual results of pediatric autism patient assessments to the Department of Health Services.

• Requires a three-fourths vote in both houses of the legislature for the amendments to become effective.